Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Werner Rausch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|February 12, 2025
Emerging mechanisms and therapeutics in inflammatory muscle diseasesSven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 18, 2018
Acute Corticonuclear Tract Ischemic Stroke with Isolated Central Facial PalsyMarc E Wolf, Hans-Werner Rausch, Philipp Eisele, et al.
Neurological Research and Practice|December 16, 2020
The use of a dedicated neurological triage system improves process times and resource utilization: a prospective observational study from an interdisciplinary emergency departmentCarolin Hoyer, Patrick Stein, Hans-Werner Rausch, et al.
Clinical Chemistry|May 28, 2026
Age-Dependent z Scores and eGFR-Adjusted Reference Ranges for Neurofilament Light: A Practical Approach for Clinical LaboratoriesOsman Evliyaoglu, Peter Findeisen, Hans-Werner Rausch, et al.
Neuropsychiatric Disease and Treatment|February 28, 2020
Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational StudyCarolin Hoyer, Patrick Stein, Anne Ebert, et al.
BMJ Open|July 8, 2026
Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort studyRebekka Rust, Sara Samadzadeh, Anna-Lena Röper, et al.
Nature Aging|June 4, 2024
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositisSven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|February 12, 2025
Emerging mechanisms and therapeutics in inflammatory muscle diseasesSven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 18, 2018
Acute Corticonuclear Tract Ischemic Stroke with Isolated Central Facial PalsyMarc E Wolf, Hans-Werner Rausch, Philipp Eisele, et al.
Neurological Research and Practice|December 16, 2020
The use of a dedicated neurological triage system improves process times and resource utilization: a prospective observational study from an interdisciplinary emergency departmentCarolin Hoyer, Patrick Stein, Hans-Werner Rausch, et al.
Clinical Chemistry|May 28, 2026
Age-Dependent z Scores and eGFR-Adjusted Reference Ranges for Neurofilament Light: A Practical Approach for Clinical LaboratoriesOsman Evliyaoglu, Peter Findeisen, Hans-Werner Rausch, et al.
Neuropsychiatric Disease and Treatment|February 28, 2020
Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational StudyCarolin Hoyer, Patrick Stein, Anne Ebert, et al.
BMJ Open|July 8, 2026
Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort studyRebekka Rust, Sara Samadzadeh, Anna-Lena Röper, et al.
Nature Aging|June 4, 2024
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositisSven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Pageof 1